IDiyas

For the Inventor, By the Inventor

Grossostheim, Germany

Tilmann Schuster

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 65(Granted Patents)


Location History:

  • Frankfurt-am-Main, DE (2007 - 2012)
  • Grossostheim, DE (2012 - 2015)

Company Filing History:

goldMedal10 out of 36 
 
Aeterna Zentaris Gmbh
 patents
silverMedal4 out of 22 
 
Zentaris Gmbh
 patents

Years Active: 2007-2015

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. 8937068 - Pyridopyrazine derivatives and their use (2015-01-20),
2. 8912189 - Pyridopyrazine derivatives and their use (2014-12-16),
3. 8791118 - Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitors (2014-07-29),
4. 8604196 - Modulating signal transduction pathways with 1-ethyl-3-[3-(1-methyl-1H-pyrazol-4-yl)-pyrido[2.3-B]pyrazine-6-yl]thiourea (2013-12-10),
5. 8541462 - Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors (2013-09-24),
6. 8536332 - Modulating signal transduction pathways with substituted pyridol [2,3-b] pyrazines (2013-09-17),
7. 8507486 - Pyridopyrazine derivatives, process of manufacturing and uses thereof (2013-08-13),
8. 8461178 - Naphthyridine derivatives and the use thereof as kinase inhibitors (2013-06-11),
9. 8394801 - Quinoxaline derivatives and their use for treating benign and malignant tumour disorders (2013-03-12),
10. 8217042 - Pyridopyrazines and their use as modulators of kinases (2012-07-10),
11. 8202883 - Substituted pyrido[2,3-b]pyrazine compounds as modulators of tyrosine kinases (2012-06-19),
12. 8148546 - Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors (2012-04-03),
13. 7211588 - N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparation (2007-05-01),
14. 7205299 - Indole derivatives having an apoptosis-inducing effect (2007-04-17),

Title: Unveiling the Innovations of Inventor Tilmann Schuster

Introduction:

Meet inventor Tilmann Schuster, a trailblazer in the field of pharmaceutical innovations hailing from Grossostheim, Germany. With an impressive portfolio of 14 patents to his name, Schuster is a visionary whose contributions have significantly impacted the realm of medical advancements.

Latest Patents:

One of Schuster's latest patents involves Pyridopyrazine derivatives and their use. These compounds hold promise in treating or preventing various physiological and pathophysiological conditions in mammals, particularly in humans. The formulaic innovations present in these patents signify Schuster's dedication to advancing healthcare through novel solutions.

Career Highlights:

Throughout his career, Schuster has made significant strides in the pharmaceutical industry, with notable stints at companies like Aeterna Zentaris GmbH and Zentaris GmbH. His expertise and innovative mindset have paved the way for groundbreaking developments in the field of medicine, solidifying his reputation as a distinguished inventor.

Collaborations:

Schuster's collaborative efforts have further amplified the impact of his inventions. Working alongside esteemed professionals such as Eckhard Guenther and Emmanuel Polymeropoulos, Schuster has harnessed collective expertise and creativity to drive forward cutting-edge research and development initiatives.

Conclusion:

Inventor Tilmann Schuster's unwavering commitment to innovation and scientific excellence continues to shape the landscape of pharmaceutical advancements. His prolific contributions underscore his status as a visionary inventor, dedicated to transforming the field of medicine for the betterment of society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…